BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38357781)

  • 1. Yifei Sanjie formula alleviates lung cancer progression via regulating PRMT6-YBX1-CDC25A axis.
    Tang J; Yin C; Chen M; Dong M; Xu Y
    Environ Toxicol; 2024 May; 39(5):3225-3237. PubMed ID: 38357781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
    Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
    Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.
    Fu L; Yang M; Ma Y
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):62-68. PubMed ID: 38279484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
    Su H; Fan G; Huang J; Qiu X
    Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Insights into Yifei Sanjie Pill's Regulation of EMT to Enhance Gefitinib Treatment effect in NSCLC by in silico analysis and experimental validation.
    Zhou R; Qin B; Zhuang Z; Li J; Tiangi Gao YS; Wu D; Yuan Y; Tang Y; Lin L
    J Ethnopharmacol; 2024 May; ():118343. PubMed ID: 38750985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective sorting and secretion of hY4 RNA fragments into extracellular vesicles mediated by methylated YBX1 to promote lung cancer progression.
    Li C; Wang W; Sun Y; Ni Y; Qin F; Li X; Wang T; Guo M; Sun G
    J Exp Clin Cancer Res; 2022 Apr; 41(1):136. PubMed ID: 35410432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Wu Y; Zuo Q; Luo W; Wang H; Pi D; Chen Q; Chen L; Lin L; Ouyang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1839-1849. PubMed ID: 38081600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.
    Su H; Fan G; Huang J; Qiu X
    Cell Death Dis; 2022 Apr; 13(4):307. PubMed ID: 35387975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.
    Lin Y; Zhang J; Li Y; Guo W; Chen L; Chen M; Chen X; Zhang W; Jin X; Jiang M; Xiao H; Wang C; Song C; Fu F
    J Transl Med; 2022 Jan; 20(1):17. PubMed ID: 34991621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18.
    Tang J; Meng Q; Shi R; Xu Y
    Mol Med Rep; 2020 Oct; 22(4):3161-3172. PubMed ID: 32945431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircFNDC3B knockdown restrains the progression of oesophageal squamous cell carcinoma through miR-214-3p/CDC25A axis.
    Wang J; Li X; Duan C; Jia Y
    Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1209-1220. PubMed ID: 36184488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
    Hartley AV; Wang B; Mundade R; Jiang G; Sun M; Wei H; Sun S; Liu Y; Lu T
    Sci Rep; 2020 Sep; 10(1):15934. PubMed ID: 32985589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
    Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
    J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
    Yu M; Xue Y; Zheng J; Liu X; Yu H; Liu L; Li Z; Liu Y
    Mol Cancer; 2017 Jun; 16(1):110. PubMed ID: 28651608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue.
    Wu Y; Zhou S; Pi D; Dong Y; Wang W; Ye H; Yi Z; Chen Y; Lin L; Ouyang M
    J Oncol; 2023; 2023():5486017. PubMed ID: 36814560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Wu Y; Pi D; Chen Y; Zuo Q; Lin L; Ouyang M
    Evid Based Complement Alternat Med; 2022; 2022():2357616. PubMed ID: 36045663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA UBR1 promotes the proliferation, migration, and invasion but represses apoptosis of lung cancer cells via modulating microRNA-545-5p/SSFA2 axis.
    Su P; Mao F; Zhang J; Zhang H; Wang M; Xu Y; Tian Z
    Bioengineered; 2021 Dec; 12(2):12135-12147. PubMed ID: 34787049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
    Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
    BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.